av/torrent-pharmaceuticals--big.svg

NSE:TORNTPHARM

Torrent Pharmaceuticals Limited

  • Stock

INR

Last Close

3,322.00

02/05 08:51

Market Cap

1.00T

Beta: 0.23

Volume Today

88.21K

Avg: 264.27K

PE Ratio

59.48

PFCF: -

Dividend Yield

0.30%

Payout:0%

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe NowHelp
Mar '15
Mar '16
Mar '17
Mar '18
Mar '19
Mar '20
Mar '21
Mar '22
Mar '23
Mar '24
Mar '25
average inventory
10.37B
-
12.13B
16.97%
14.59B
20.29%
17.63B
20.85%
19.51B
10.67%
20.42B
4.66%
24.15B
18.27%
25.72B
6.50%
23.46B
8.77%
22.55B
3.91%
24.10B
6.90%
average payables
16.64B
-
20.97B
26.06%
23.16B
10.43%
21.73B
6.18%
20.72B
4.63%
20.87B
0.69%
20.72B
0.72%
18.71B
9.71%
16.77B
10.37%
18.84B
12.37%
19.55B
3.75%
average receivables
17.85B
-
20.12B
12.66%
9.47B
52.90%
9.67B
-
9.67B
0%
8.26B
14.66%
17.30B
109.47%
18.77B
8.52%
20.41B
8.73%
18.56B
9.07%
book value per share
73.59
-
100.13
36.07%
128.53
28.36%
136.57
6.25%
139.59
2.21%
142.51
2.09%
172.47
21.02%
175.89
1.98%
183.15
4.13%
202.58
10.61%
224.31
10.73%
capex per share
-7.17
-
-17.85
149.01%
-14.38
19.41%
-23.38
62.54%
-19.58
16.23%
-12.02
38.63%
-9.90
17.61%
-5.99
39.56%
-16.96
183.39%
12.79
175.39%
18.06
41.20%
capex to depreciation
-1.27
-
-2.45
93.03%
-1.59
35.39%
-1.94
22.09%
-1.07
44.59%
-0.62
42.07%
-0.51
18.04%
-0.31
39.94%
-0.81
165.30%
0.54
167.03%
0.77
41.23%
capex to operating cash flow
-0.30
-
-0.22
25.64%
-0.48
115.93%
-0.88
84.08%
-0.37
58.34%
-0.29
20.71%
-0.17
42.97%
-0.11
32.60%
-0.24
115.75%
0.13
154.67%
0.24
78.38%
capex to revenue
-0.05
-
-0.09
74.89%
-0.09
7.37%
-0.14
57.40%
-0.09
34.24%
-0.05
41.14%
-0.04
18.72%
-0.02
43.38%
-0.06
152.06%
0.04
167.28%
0.05
30.02%
cash per share
25.51
-
41.52
62.78%
50.05
20.55%
40.17
19.74%
34.49
14.13%
19.57
43.26%
21.81
11.43%
17.22
21.01%
24.67
43.25%
29.67
20.23%
20.42
31.17%
days of inventory on hand
264.16
-
300.77
13.86%
301.33
0.19%
403.92
34.05%
304.23
24.68%
348.10
14.42%
437.81
25.77%
354.19
19.10%
297.61
15.98%
140.29
52.86%
334.10
138.16%
days payables outstanding
460.46
-
517.02
12.28%
444.10
14.10%
420.76
5.26%
329.64
21.66%
336.54
2.09%
337.49
0.28%
240.86
28.63%
224.07
6.97%
128.61
42.60%
239.30
86.07%
days sales outstanding
169.65
-
106.09
37.46%
94.65
-
76.43
-
78.37
2.55%
75.05
4.24%
63.47
15.43%
59.17
6.77%
debt to assets
0.35
-
0.26
24.24%
0.25
5.53%
0.45
83.01%
0.43
5.76%
0.42
2.71%
0.35
16.76%
0.31
10.29%
0.36
15.10%
0.26
26.89%
0.21
18.29%
debt to equity
1.10
-
0.70
36.57%
0.58
17.32%
1.40
142.30%
1.28
8.58%
1.21
5.26%
0.84
31.04%
0.68
18.13%
0.87
26.69%
0.57
33.69%
0.42
26.55%
dividend yield
0.01
-
0.04
263.51%
0.01
79.06%
0.01
59.39%
0.01
22.04%
0.02
123.55%
0.01
63.51%
0.01
82.31%
0.02
15.80%
0.01
32.41%
0.01
10.36%
earnings yield
0.04
-
0.08
98.28%
0.04
53.21%
0.03
10.94%
0.01
57.12%
0.03
126.32%
0.03
5.35%
0.02
43.41%
0.02
45.50%
0.02
23.57%
0.02
3.05%
enterprise value
217.81B
-
244.01B
12.03%
285.05B
16.82%
276.51B
3.00%
376.01B
35.99%
385.46B
2.51%
473.70B
22.89%
509.17B
7.49%
568.78B
11.71%
937.33B
64.80%
1.10T
17.75%
enterprise value over ebitda
17.16
-
8.48
50.58%
18.54
118.62%
17.37
6.28%
18.79
8.14%
17.03
9.33%
18.76
10.14%
19.47
3.77%
19.70
1.20%
26.77
35.90%
29.66
10.79%
ev to operating cash flow
26.88
-
8.99
66.55%
28.15
212.98%
30.92
9.86%
20.91
32.37%
27.69
32.44%
23.56
14.93%
28.24
19.87%
24.02
14.95%
28.70
19.48%
42.70
48.77%
ev to sales
4.76
-
3.74
21.32%
5.03
34.27%
4.72
6.06%
5.04
6.74%
4.95
1.68%
6.01
21.24%
6.05
0.69%
6.01
0.63%
8.84
47.06%
9.58
8.44%
free cash flow per share
16.77
-
62.32
271.58%
15.54
75.07%
3.04
80.43%
33.54
1,002.93%
29.10
13.23%
49.51
70.10%
47.29
4.48%
53.01
12.11%
83.72
57.91%
58.33
30.32%
free cash flow yield
0.03
-
0.09
221.22%
0.02
78.48%
0.00
76.00%
0.04
635.12%
0.03
16.40%
0.04
31.79%
0.03
12.93%
0.03
1.81%
0.03
9.27%
0.02
41.45%
graham net net
-71.72
-
-62.60
12.70%
-97.53
55.79%
-215.04
120.48%
-171.68
20.16%
-220.96
28.70%
-145.38
34.20%
-117.51
19.17%
-159.70
35.91%
-138.21
13.46%
-119.30
13.68%
graham number
191.67
-
338.61
76.66%
282.44
16.59%
248.13
12.15%
201.21
18.91%
311.58
54.85%
378.87
21.59%
301.46
20.43%
389.37
29.16%
472.31
21.30%
533.86
13.03%
income quality
0.86
-
1.15
33.15%
0.93
18.92%
0.96
3.19%
3.20
233.32%
1.17
63.36%
1.32
12.31%
1.47
11.64%
1.28
12.83%
1.97
53.80%
1.35
31.40%
intangibles to total assets
0.24
-
0.21
13.83%
0.18
13.79%
0.40
121.50%
0.36
9.41%
0.34
6.72%
0.31
8.51%
0.29
5.47%
0.36
24.44%
0.33
9.62%
0.31
6.04%
interest coverage
5.32
-
13.86
160.58%
5.34
61.47%
3.09
42.22%
2.73
11.50%
3.59
31.36%
5.24
46.13%
7.72
47.32%
6.55
15.24%
7.17
9.46%
interest debt per share
85.58
-
75.24
12.08%
80.16
6.55%
199.95
149.43%
193.21
3.37%
185.80
3.84%
154.54
16.83%
127.72
17.35%
168.47
31.90%
126.78
24.74%
94.62
25.37%
inventory turnover
1.38
-
1.21
12.17%
1.21
0.19%
0.90
25.40%
1.20
32.77%
1.05
12.60%
0.83
20.49%
1.03
23.61%
1.23
19.01%
2.60
112.14%
1.09
58.01%
invested capital
1.10
-
0.70
36.57%
0.58
17.32%
1.40
142.30%
1.28
8.58%
1.21
5.26%
0.84
31.04%
0.68
18.13%
0.87
26.69%
86.85B
10,027,701,248,037.11%
93.30B
7.43%
market cap
196.06B
-
226.80B
15.68%
262.74B
15.84%
214.29B
18.44%
321.51B
50.03%
333.67B
3.78%
430.68B
29.07%
472.46B
9.70%
520.18B
10.10%
905.46B
74.07%
1.08T
19.00%
net current asset value
-13.61B
-
-9.62B
29.35%
-3.90B
59.43%
-43.58B
1,016.71%
-43.59B
0.02%
-42.06B
3.52%
-27.16B
35.42%
-19.82B
27.03%
-35B
76.60%
-25.93B
25.92%
-17.76B
31.51%
net debt to ebitda
1.71
-
0.60
65.11%
1.45
142.68%
3.91
169.41%
2.72
30.35%
2.29
15.96%
1.70
25.55%
1.40
17.60%
1.68
19.93%
0.91
45.93%
0.70
22.56%
net income per share
22.19
-
50.89
129.36%
27.58
45.80%
20.04
27.36%
12.89
35.66%
30.28
134.88%
36.99
22.17%
22.96
37.92%
36.79
60.21%
48.94
33.03%
56.47
15.38%
operating cash flow per share
23.94
-
80.17
234.88%
29.92
62.68%
26.42
11.70%
53.13
101.09%
41.12
22.60%
59.41
44.47%
53.27
10.33%
69.97
31.35%
96.50
37.91%
76.39
20.84%
payables turnover
0.79
-
0.71
10.94%
0.82
16.42%
0.87
5.55%
1.11
27.64%
1.08
2.05%
1.08
0.28%
1.52
40.12%
1.63
7.49%
2.84
74.23%
1.53
46.26%
receivables turnover
2.15
-
3.44
59.91%
3.86
-
4.78
-
4.66
2.48%
4.86
4.43%
5.75
18.24%
6.17
7.27%
research and ddevelopement to revenue
0.00
-
0.00
36.92%
0.01
-
0.00
73.15%
0.00
43.78%
0.00
28.03%
0.05
1,403.94%
0.05
1.53%
return on tangible assets
0.13
-
0.24
92.82%
0.11
53.44%
0.08
29.68%
0.05
38.90%
0.11
127.66%
0.13
16.82%
0.08
34.88%
0.13
55.34%
0.16
25.76%
0.18
12.61%
revenue per share
135.29
-
192.63
42.38%
167.59
13.00%
173.06
3.26%
220.47
27.39%
229.87
4.26%
233.01
1.37%
248.75
6.75%
279.66
12.43%
313.36
12.05%
340.30
8.60%
roe
0.30
-
0.51
68.56%
0.21
57.77%
0.15
31.64%
0.09
37.05%
0.21
130.06%
0.21
0.95%
0.13
39.13%
0.20
53.86%
0.24
20.27%
0.25
4.20%
roic
0.13
-
0.32
150.84%
0.14
57.35%
0.06
54.40%
0.10
59.82%
0.13
31.19%
0.14
9.83%
0.12
13.63%
0.13
2.71%
0.17
30.90%
0.35
112.25%
sales general and administrative to revenue
0.05
-
0.03
29.99%
0.08
142.25%
0.10
24.76%
0.08
18.02%
0.08
4.71%
0.07
5.76%
0.07
10.29%
0.06
1.60%
0.07
12.29%
shareholders equity per share
73.59
-
100.13
36.07%
128.53
28.36%
136.57
6.25%
139.59
2.21%
142.51
2.09%
172.47
21.02%
175.89
1.98%
183.15
4.13%
202.58
10.61%
224.31
10.73%
stock based compensation to revenue
tangible asset value
5.80B
-
15.13B
160.92%
25.34B
67.43%
-10.39B
141.01%
-3.60B
65.30%
1.08B
129.98%
15.12B
1,298.75%
21.47B
42.03%
7.71B
64.10%
19.35B
151.01%
29.89B
54.45%
tangible book value per share
17.14
-
44.71
160.92%
74.86
67.43%
-30.70
141.01%
-10.65
65.30%
3.19
129.98%
44.67
1,298.75%
63.45
42.03%
22.78
64.09%
57.18
150.98%
88.32
54.46%
working capital
12.28B
-
13.78B
12.24%
22.23B
61.33%
601.50M
97.29%
-1.28B
312.44%
-4.73B
270.36%
6.30B
233.10%
7.50B
19.05%
-1.33B
117.74%
1.86B
240.02%
9.06B
386.50%

All numbers in INR (except ratios and percentages)